Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 4 Recruiting 3 Withdrawn 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Neoplasms 1

Interventions

pembrolizumab 116 Carboplatin 48 Nivolumab 46 Paclitaxel 35 Cyclophosphamide 35 Cisplatin 34 Gemcitabine 30 atezolizumab 25 Specimen Handling 25 venetoclax 24 Pemetrexed 24 Magnetic Resonance Spectroscopy 24 fludarabine 22 Ipilimumab 22 Docetaxel 22 Bevacizumab 22 Biopsy 21 Radiotherapy 20 Azacitidine 20 Fluorouracil 19 Dexamethasone 19 Radiosurgery 18 durvalumab 17 Leucovorin 16 olaparib 14 Trastuzumab 14 Cetuximab 14 Capecitabine 14 fludarabine phosphate 13 Lenalidomide 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × FAPI-46 × 1 year × Clear all

NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Aalborg University Hospital

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡